As part of its Healthcare investment platform, LIAN Group, an innovative owner- operator, announces the acquisition of Scientis, a pioneering Swiss Cosmeceutical company. This acquisition strengthens and expands LIAN’s growing footprint in the healthcare industry, where it focuses on investing in the build-out of companies with leading solutions that address evolving needs. Scientis is a Swiss dermatology company dedicated to skin pigmentation with its flagship product Cyspera®. The Cyspera® product line, contains the proprietary Cysteamine Isobionic-Amide Complex™ , a clinically proven pigment corrector. Its unique formula features powerful antioxidant properties, and positions Cyspera as the first topical product to...

As part of their Healthcare investment platform, LIAN Group, an innovative investor and operator known for its healthcare investment in the #1 Swiss dentistry network, Cheeze, announces the acquisition of Scientis, a pioneering Swiss Cosmeceutical company. This acquisition strengthens LIAN’s healthcare footprint, as part of their cross-industry investments, focusing on leading solutions that address evolving needs. Scientis is a Swiss dermatology company dedicated to skin pigmentation with its flagship product Cyspera®. The Cyspera® product line,...